Brazil’s Butantan aims to supply 40 million doses of its own Covid-19 vaccine by year-end

RIO DE JANEIRO, BRAZIL – (REUTERS) Brazil’s Butantan Institute could supply at least 40 million doses of its own Covid-19 vaccine, called ButanVac, in the fourth quarter of 2021, said Director Dimas Covas on Thursday, May 27.

Speaking before a Senate panel investigating the federal government’s handling of the pandemic, Covas said clinical trials of the new vaccine can be concluded quickly, though they still need to be authorized by Brazilian health regulator ANVISA.

Related coverage: Unemployment rate in Brazil reaches 14.7%, the highest level since 2012 · Brazil's Bolsonaro says chaos and panic are promoted by those who want to return to power · Strike at Argentine ports ends after vaccination deal, unions say · Brazil's left takes to streets to bolster Covid CPI and erode Bolsonaro support

More: Brazil news in English, every day from The Rio Times.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

Brazil runoff, Sunday, October 25: Brazil runoff start time and results schedule. Latest: Brazil runoff polls, Flávio 51%, Lula 49%.